
Johnson & Johnson
NYSE:JNJ

Johnson & Johnson?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
142.06
167.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Johnson & Johnson hold over its rivals?
What risks and challenges
does Johnson & Johnson face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Johnson & Johnson.
Provide an overview of the primary business activities
of Johnson & Johnson.
What unique competitive advantages
does Johnson & Johnson hold over its rivals?
What risks and challenges
does Johnson & Johnson face in the near future?
Has there been any significant insider trading activity
in Johnson & Johnson recently?
Summarize the latest earnings call
of Johnson & Johnson.
What significant events have occurred
in Johnson & Johnson over the past months?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Johnson & Johnson.
Provide P/S
for Johnson & Johnson.
Provide P/E
for Johnson & Johnson.
Provide P/OCF
for Johnson & Johnson.
Provide P/FCFE
for Johnson & Johnson.
Provide P/B
for Johnson & Johnson.
Provide EV/S
for Johnson & Johnson.
Provide EV/GP
for Johnson & Johnson.
Provide EV/EBITDA
for Johnson & Johnson.
Provide EV/EBIT
for Johnson & Johnson.
Provide EV/OCF
for Johnson & Johnson.
Provide EV/FCFF
for Johnson & Johnson.
Provide EV/IC
for Johnson & Johnson.
Show me price targets
for Johnson & Johnson made by professional analysts.
What are the Revenue projections
for Johnson & Johnson?
How accurate were the past Revenue estimates
for Johnson & Johnson?
What are the Net Income projections
for Johnson & Johnson?
How accurate were the past Net Income estimates
for Johnson & Johnson?
What are the EPS projections
for Johnson & Johnson?
How accurate were the past EPS estimates
for Johnson & Johnson?
What are the EBIT projections
for Johnson & Johnson?
How accurate were the past EBIT estimates
for Johnson & Johnson?
Compare the revenue forecasts
for Johnson & Johnson with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Johnson & Johnson and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Johnson & Johnson against its competitors.
Analyze the profit margins
(gross, operating, and net) of Johnson & Johnson compared to its peers.
Compare the P/E ratios
of Johnson & Johnson against its peers.
Discuss the investment returns and shareholder value creation
comparing Johnson & Johnson with its peers.
Analyze the financial leverage
of Johnson & Johnson compared to its main competitors.
Show all profitability ratios
for Johnson & Johnson.
Provide ROE
for Johnson & Johnson.
Provide ROA
for Johnson & Johnson.
Provide ROIC
for Johnson & Johnson.
Provide ROCE
for Johnson & Johnson.
Provide Gross Margin
for Johnson & Johnson.
Provide Operating Margin
for Johnson & Johnson.
Provide Net Margin
for Johnson & Johnson.
Provide FCF Margin
for Johnson & Johnson.
Show all solvency ratios
for Johnson & Johnson.
Provide D/E Ratio
for Johnson & Johnson.
Provide D/A Ratio
for Johnson & Johnson.
Provide Interest Coverage Ratio
for Johnson & Johnson.
Provide Altman Z-Score Ratio
for Johnson & Johnson.
Provide Quick Ratio
for Johnson & Johnson.
Provide Current Ratio
for Johnson & Johnson.
Provide Cash Ratio
for Johnson & Johnson.
What is the historical Revenue growth
over the last 5 years for Johnson & Johnson?
What is the historical Net Income growth
over the last 5 years for Johnson & Johnson?
What is the current Free Cash Flow
of Johnson & Johnson?
Discuss the annual earnings per share (EPS)
trend over the past five years for Johnson & Johnson.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.4B USD | 12.5 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
699.1B USD | 33.9 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
211.2B CHF | 9.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
184.2B CHF | 10.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
166.2B GBP | 131 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
193.3B USD | 8.3 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 261.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
133.5B USD | 7.3 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
109.7B EUR | 4.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Average EV/EBITDA:
394.4
12.5
|
7%
|
1.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
33.9
|
30%
|
1.1 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.3
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.6
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10.3
|
5%
|
2.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.3
|
8%
|
1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
261.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.3
|
2%
|
3.7 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
4.8
|
7%
|
0.7 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.